Researchers are excited about the medication , a groundbreaking dual agonist showing remarkable results in initial trials for size reduction . It works by targeting several pathways : GLP-1 and GIP, https://nicolasplzd072294.blog-kids.com/41199557/this-new-possibility-for-body-loss